Our results showed that desuccinylate SIRT5 expression was elevated in AML clinical samples, consistent with the study of Yan et al. [23], hence it was suggested that SIRT5 serves as a key regulator mediating AML development. This evidence concerns the gene SIRT5 and acute myeloid leukemia.